Answers are grounded in this paper and cite their sources.
Objective: Influenza and pneumococcal infections, cause life-threatening conditions in geriatric population by physiological changes and comorbid diseases. In our study, the pneumococcal/influenza vaccination status of the geriatric population hospitalized with the diagnosis of respiratory infections and their effects to the prognostic and demographic factors of the patients and the costs of hospitalization, were investigated. Material and Methods: Sociodemographic clinical findings and pneumococcal/influenza vaccination status of patients hospitalized with the diagnosis of non coronavirus disease-2019 respiratory tract infections between 1st January and 31th December 2022, were analyzed retrospectively. Results: A total of 944 patients were evaluated in our study. We determinated that 75.5% of all patients were discharged and 24.6% of patients died. It was determined that 12.3% of the patients had both pneumococcal and influenza vaccines, 9.7% were vaccinated only with influenza and 56.9% were not vaccinated with any vaccine. Pneumococcal and/or influenza protected patients were found to have significantly lower mortality rates and hospitalization costs compared to patients without vaccine protection (p<0.001). It was observed that single influenza vaccine protection was more effective and protective than single pneumococcal vaccine protection. Conclusion: Influenza vaccine addition to the routine vaccination program might significantly reduces the financial burden on the hospital/state for geriatric patients.
No takes yet. Share an insight, caveat, or question.
GÖÇMEN et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: